Individualized Treatments in Adults With Relapsed/Refractory Cancers
Sponsor: Case Comprehensive Cancer Center
This NA trial investigates Refractory Cancer and Relapsed Cancer and is currently ongoing. Case Comprehensive Cancer Center leads this study, which shows 10 recorded versions since 2023 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
10 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2025 — Feb 2026 [monthly]
Recruiting NA
-
Sep 2024 — Sep 2025 [monthly]
Recruiting NA
-
Aug 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jul 2024 — Aug 2024 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
May 2024 — Jul 2024 [monthly]
Recruiting NA
-
Feb 2024 — May 2024 [monthly]
Recruiting NA
-
Dec 2023 — Feb 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Nov 2023 — Dec 2023 [monthly]
Not Yet Recruiting NA
-
Oct 2023 — Nov 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Case Comprehensive Cancer Center
- Community Foundation of Broward
- Florida International University
For direct contact, visit the study record on ClinicalTrials.gov .